IGM Biosciences

1 follower


IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic application... Read more

Industries

Employees

51-200

Links


Org chart

Mary Beth Harler
Chief Executive Officer
Collapse
Angus M. Sinclair
SVP, Immuno-Oncology
Bruce Keyt
Chief Scientific Officer
Elizabeth Haanes
SVP, Intellectual Property
Lisa L. Decker
Chief Business Officer
Suzette Tauber
Chief Human Resources Officer
Sameer Sachdeva
Drug Product Development Lead

Board & advisors